Prof Raphael Mechoulam from The Hebrew University School of Pharmacy  began his cannabinoid experiments in the 1960s in Israel. His research team was the first to isolate delta9-THC (THC), the psychoactive component of cannabis, which affects the brain, consciousness, and creativity as well as Cannabidiol (CBD), the most important substance in the plant with medical benefits.

Among Mechoulam’s many other achievements are the design and synthesis of numerous important novel cannabinoids that have important therapeutic potential as pharmaceutical drugs.

To read the full article please visit Canadian Friends of The Hebrew University’s website.